These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24709416)

  • 21. Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China.
    Zhao LL; Xia Q; Lin N; Liu B; Zhao XQ; Liu Z; Wan KL
    J Microbiol Methods; 2012 Oct; 91(1):212-4. PubMed ID: 22766324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Mycobacterium tuberculosis drug susceptibility using solid and liquid culture in Nigeria.
    Lawson L; Emenyonu N; Abdurrahman ST; Lawson JO; Uzoewulu GN; Sogaolu OM; Ebisike JN; Parry CM; Yassin MA; Cuevas LE
    BMC Res Notes; 2013 May; 6():215. PubMed ID: 23721428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experience of using TB test kit for the rapid drug susceptibility testing of M. tuberculosis.].
    Domotenko LV; Morozova TP; Shemyakin IG; Shepelin AP
    Klin Lab Diagn; 2020; 65(2):122-130. PubMed ID: 32159311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.
    Gallo JF; Pinhata JMW; Saraceni CP; de Oliveira RS
    J Microbiol Methods; 2017 Aug; 139():168-171. PubMed ID: 28601653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.
    Pfyffer GE; Palicova F; Rüsch-Gerdes S
    J Clin Microbiol; 2002 May; 40(5):1670-4. PubMed ID: 11980940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system.
    Kontos F; Nicolaou S; Kostopoulos C; Gitti Z; Petinaki E; Maniati M; Anagnostou S; Raftopoulou A; Papageorgiou P; Scrioubellou A; Tselentis I; Maniatis AN
    J Microbiol Methods; 2003 Oct; 55(1):331-3. PubMed ID: 14500027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.
    Scarparo C; Ricordi P; Ruggiero G; Piccoli P
    J Clin Microbiol; 2004 Mar; 42(3):1109-14. PubMed ID: 15004061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for
    Sivaramakrishnan G; Subramanyam B; Kumar MP; Golla R; Tripathy SP; Mondal R
    Int J Mycobacteriol; 2019; 8(4):329-332. PubMed ID: 31793501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960.
    Christianson S; Voth D; Wolfe J; Sharma MK
    PLoS One; 2014; 9(9):e108911. PubMed ID: 25259734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System.
    Rodrigues C; Jani J; Shenai S; Thakkar P; Siddiqi S; Mehta A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1449-55. PubMed ID: 19017456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.
    Sturegård E; Ängeby KA; Werngren J; Juréen P; Kronvall G; Giske CG; Kahlmeter G; Schön T
    Clin Microbiol Infect; 2015 Feb; 21(2):148.e5-7. PubMed ID: 25640156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
    Banaiee N; Bobadilla-Del-Valle M; Riska PF; Bardarov S; Small PM; Ponce-de-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Med Microbiol; 2003 Jul; 52(Pt 7):557-561. PubMed ID: 12808076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of proportion method in Löwenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates].
    Gül Yurtsever S; Biçmen C; Gündüz AT; Ozkütük N; Salman S; Demirci M
    Mikrobiyol Bul; 2011 Oct; 45(4):623-31. PubMed ID: 22090293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.
    Rüsch-Gerdes S; Pfyffer GE; Casal M; Chadwick M; Siddiqi S
    J Clin Microbiol; 2006 Mar; 44(3):688-92. PubMed ID: 16517840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of nitrate reductase and automatic BACTEC MGIT 960 AST techniques for determining the drug sensitivity of mycobacteria tuberculosis].
    Golyshevskaia VI; Irtuganova OA; Smirnova NS; Domotenko LV
    Probl Tuberk Bolezn Legk; 2003; (8):34-7. PubMed ID: 14524099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.